Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis

PurposeTo compare the efficacy and safety of transarterial chemoembolization plus donafenib (TACE+D) and TACE plus donafenib combined with camrelizumab (TACE+D+C) in unresectable hepatocellular carcinoma (uHCC), using propensity score matching (PSM) to minimize selection bias.MethodsA single-center...

Descrición completa

Detalles Bibliográficos

Principais autores:	Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-04-01
Series:	Frontiers in Immunology
Assuntos:	Camrelizumab donafenib interventional treatment transarterial chemoembolization unresectable hepatocellular carcinoma
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1694973/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!